Register for our S/EIS Fund

We are excited to announce that o2h discovery was the Finalist in the prestigious ‘Best Performing R&D Service Provider of the Year’ at ON Awards 2024 organised by One Nucleus, a not-for-profit Life Sciences & Healthcare organisation.

The ‘Best Performing R&D Service Provider of the Year‘ category acknowledges organisations that have demonstrated remarkable achievements in the field of drug discovery services. This recognition highlights our dedication to providing outstanding drug discovery research services that drive innovation and progress within the biotech industry.

o2h discovery – Finalist at the ‘Best Performing R&D Service Provider of the Year’ at ON Awards 2024)

o2h discovery – Finalist at the ‘Best Performing R&D Service Provider of the Year’ at ON Awards 2024)

The evaluation process for this esteemed category took into consideration various aspects, including business performance, customer service performance, adoption of innovation into the services provided, flexible support of start-up companies, collaboration with academia to enable translational research and effective ESG (environment, social and governance) strategy.

Sunil Shah, Co-Founder of the o2h group, attended The ON Awards ceremony on March 21, 2024, in London, UK, joining industry leaders, innovators, and influencers to honour achievements in the life sciences sector. o2h discovery is proud to celebrate the industry’s collective successes and remains committed to making significant and impactful contributions to the global Biotech and Pharma industry.

Sunil Shah in conversation with other attendees at the ON Awards 2024

(Sunil Shah in conversation with other attendees at the ON Awards 2024)

About o2h discovery

Founded in 2005, o2h discovery is a Contract Research Organisation with an integrated drug discovery platform operating from its state-of-the-art research centre in Ahmedabad, India and Cambridge, UK. We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development.

For more information about o2h discovery, visit: https://o2hdiscovery.co/ or email discovery@o2h.com

recent blogs

Comments are closed.